Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karin Jordan

Showing results (91-100 of 105) with videos related to

Pageof 11
Sort By:
Journal of Cancer Research and Clinical Oncology|July 19, 2023
A patient survey indicates quality of life and progression-free survival as equally important outcome measures in multiple myeloma clinical trialsAnna Fleischer, Larissa Zapf, Johannes Allgaier, et al.
Transplantation and Cellular Therapy|July 2, 2021
Local Radiation Therapy Before and During Induction Delays Stem Cell Mobilization and Collection in Multiple Myeloma PatientsSandra Sauer, Katharina Erdmann, Alexandra D Jensen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2015
Antiemetics: American Society of Clinical Oncology Focused Guideline UpdatePaul J Hesketh, Kari Bohlke, Gary H Lyman, et al.
Frontiers in Oncology|May 8, 2023
Impact of novel agent therapies on immune cell subsets and infectious complications in patients with relapsed/refractory multiple myelomaLukas John, Kaya Miah, Axel Benner, et al.
Oncology Reviews|April 6, 2026
Embedding nutrition into routine oncology care: about time?Barry J A Laird, Lorenzo Antonuzzo, Darío Sánchez Cabrero, et al.
European Journal of Haematology|April 7, 2018
Nivolumab maintenance after salvage autologous stem cell transplantation results in long-term remission in multiple relapsed primary CNS lymphomaDenis Terziev, Barbara Hutter, Barbara Klink, et al.
Future Oncology (London, England)|March 19, 2025
Nausea and vomiting in an evolving anticancer treatment landscape: long-delayed and emetogenic antibody-drug conjugatesYeon Hee Park, Giampaolo Bianchini, Javier Cortés, et al.
Journal of Cachexia, Sarcopenia and Muscle|December 13, 2021
Validation of a proxy-reported SARC-F questionnaire for current and retrospective screening of sarcopenia-related functional impairmentsJohannes Maurus, Tobias Terzer, Axel Benner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 14, 2020
Antiemetics: ASCO Guideline UpdatePaul J Hesketh, Mark G Kris, Ethan Basch, et al.
The Oncologist|March 18, 2020
Immunotherapy in Underrepresented Populations of Patients with Cancer: Do We Have Enough Evidence at Present? A Focus on Patients with Major Viral Infections and Autoimmune DisordersAndrea Antonuzzo, Fabio Calabrò, Pietro Quaglino, et al.
Pageof 11

Showing results (91-100 of 105) with videos related to

Sort By:
Pageof 11
Journal of Cancer Research and Clinical Oncology|July 19, 2023
A patient survey indicates quality of life and progression-free survival as equally important outcome measures in multiple myeloma clinical trialsAnna Fleischer, Larissa Zapf, Johannes Allgaier, et al.
Transplantation and Cellular Therapy|July 2, 2021
Local Radiation Therapy Before and During Induction Delays Stem Cell Mobilization and Collection in Multiple Myeloma PatientsSandra Sauer, Katharina Erdmann, Alexandra D Jensen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2015
Antiemetics: American Society of Clinical Oncology Focused Guideline UpdatePaul J Hesketh, Kari Bohlke, Gary H Lyman, et al.
Frontiers in Oncology|May 8, 2023
Impact of novel agent therapies on immune cell subsets and infectious complications in patients with relapsed/refractory multiple myelomaLukas John, Kaya Miah, Axel Benner, et al.
Oncology Reviews|April 6, 2026
Embedding nutrition into routine oncology care: about time?Barry J A Laird, Lorenzo Antonuzzo, Darío Sánchez Cabrero, et al.
European Journal of Haematology|April 7, 2018
Nivolumab maintenance after salvage autologous stem cell transplantation results in long-term remission in multiple relapsed primary CNS lymphomaDenis Terziev, Barbara Hutter, Barbara Klink, et al.
Future Oncology (London, England)|March 19, 2025
Nausea and vomiting in an evolving anticancer treatment landscape: long-delayed and emetogenic antibody-drug conjugatesYeon Hee Park, Giampaolo Bianchini, Javier Cortés, et al.
Journal of Cachexia, Sarcopenia and Muscle|December 13, 2021
Validation of a proxy-reported SARC-F questionnaire for current and retrospective screening of sarcopenia-related functional impairmentsJohannes Maurus, Tobias Terzer, Axel Benner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 14, 2020
Antiemetics: ASCO Guideline UpdatePaul J Hesketh, Mark G Kris, Ethan Basch, et al.
The Oncologist|March 18, 2020
Immunotherapy in Underrepresented Populations of Patients with Cancer: Do We Have Enough Evidence at Present? A Focus on Patients with Major Viral Infections and Autoimmune DisordersAndrea Antonuzzo, Fabio Calabrò, Pietro Quaglino, et al.
Pageof 11